These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31309714)

  • 1. Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.
    Warny M; Helby J; Birgens HS; Bojesen SE; Nordestgaard BG
    J Thromb Haemost; 2019 Nov; 17(11):1898-1911. PubMed ID: 31309714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased rheumatoid factor and deep venous thrombosis: 2 cohort studies of 54628 individuals from the general population.
    Meyer-Olesen CL; Nielsen SF; Nordestgaard BG
    Clin Chem; 2015 Feb; 61(2):349-59. PubMed ID: 25278501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism.
    Green D
    Hematology Am Soc Hematol Educ Program; 2009; ():259-66. PubMed ID: 20008208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Incidence of Arterial and Venous Thrombosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Kang A; Antonelou M; Wong NL; Tanna A; Arulkumaran N; Tam FWK; Pusey CD
    J Rheumatol; 2019 Mar; 46(3):285-293. PubMed ID: 30385704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous fibrinolysis-Relevance to clinical thrombosis risk assessment.
    Kanji R; Kubica J; Navarese EP; Gorog DA
    Eur J Clin Invest; 2021 Apr; 51(4):e13471. PubMed ID: 33296082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous sex hormones and risk of venous thromboembolism in women and men.
    Holmegard HN; Nordestgaard BG; Schnohr P; Tybjaerg-Hansen A; Benn M
    J Thromb Haemost; 2014; 12(3):297-305. PubMed ID: 24329981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Incidence of Symptomatic Thrombotic Events in Adult Patients Hospitalized with Coronavirus 19: A Retrospective Cohort Study.
    Vallone MG; Vazquez C; Chuliber FA; Privitera V; Ferraris A; Cantarella RF; Indo MF; Sanchez Thomas DM; Peuchot VA; Vazquez FJ
    Clin Appl Thromb Hemost; 2021; 27():10760296211051712. PubMed ID: 34714177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP Platelet Hyperreactivity Predicts Cardiovascular Disease in the FHS (Framingham Heart Study).
    Puurunen MK; Hwang SJ; Larson MG; Vasan RS; O'Donnell CJ; Tofler G; Johnson AD
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29502103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO blood group influences risk of venous thromboembolism and myocardial infarction.
    Pang H; Zong Z; Hao L; Cao Q
    J Thromb Thrombolysis; 2020 Aug; 50(2):430-438. PubMed ID: 31820263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study.
    Sundbøll J; Hováth-Puhó E; Adelborg K; Ording A; Schmidt M; Bøtker HE; Sørensen HT
    Int J Cardiol; 2017 Aug; 241():182-187. PubMed ID: 28473169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors.
    Vasan SK; Rostgaard K; Majeed A; Ullum H; Titlestad KE; Pedersen OB; Erikstrup C; Nielsen KR; Melbye M; Nyrén O; Hjalgrim H; Edgren G
    Circulation; 2016 Apr; 133(15):1449-57; discussion 1457. PubMed ID: 26939588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
    Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.
    Sokol J; Timp JF; le Cessie S; van Hylckama-Vlieg A; Rosendaal FR; Kubisz P; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
    Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.
    Lind C; Flinterman LE; Enga KF; Severinsen MT; Kristensen SR; Braekkan SK; Mathiesen EB; Njølstad I; Cannegieter SC; Overvad K; Hansen JB
    Circulation; 2014 Feb; 129(8):855-63. PubMed ID: 24270266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis.
    Lijfering WM; Veeger NJ; Brouwer JL; van de Poel MH; van der Meer J
    J Thromb Haemost; 2007 Mar; 5(3):614-6. PubMed ID: 17181828
    [No Abstract]   [Full Text] [Related]  

  • 19. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway.
    Braekkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Størmer J; Hansen JB
    J Thromb Haemost; 2010 Jan; 8(1):157-62. PubMed ID: 19496920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.
    Jensvoll H; Blix K; Brækkan SK; Hansen JB
    PLoS One; 2014; 9(3):e92011. PubMed ID: 24642868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.